Accessibility Menu
Evolent Health logo

Evolent Health

(NYSE) EVH

Current Price$2.76
Market Cap$298.07M
Since IPO (2015)-86%
5 Year-87%
1 Year-74%
1 Month-4%

Evolent Health Financials at a Glance

Market Cap

$298.07M

Revenue (TTM)

$1.88B

Net Income (TTM)

$534.51M

EPS (TTM)

$-5.15

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$2.76

Volume

1,999,491.907

Open

$2.65

Previous Close

$2.74

Daily Range

$2.65 - $2.81

52-Week Range

$2.50 - $12.06

EVH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evolent Health

Industry

Health Care Technology

Employees

4,200

CEO

Seth B. Blackley, MBA

Headquarters

Arlington, VA 22203, US

EVH Financials

Key Financial Metrics (TTM)

Gross Margin

15%

Operating Margin

-1%

Net Income Margin

-28%

Return on Equity

-75%

Return on Capital

-1%

Return on Assets

-28%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

-2.08%

Stock Overview

Market Cap

$298.07M

Shares Outstanding

111.64M

Volume

2.00M

Short Interest

0.00%

Avg. Volume

3.08M

Financials (TTM)

Gross Profit

$283.03M

Operating Income

$4.43M

EBITDA

$361.31M

Operating Cash Flow

$38.84M

Capital Expenditure

$34.09M

Free Cash Flow

$4.75M

Cash & ST Invst.

$151.86M

Total Debt

$989.70M

Evolent Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$468.72M

-27.5%

Gross Profit

$19.60M

-125.9%

Gross Margin

-4.18%

N/A

Market Cap

$298.07M

N/A

Market Cap/Employee

$66.24K

N/A

Employees

4,500

N/A

Net Income

$429.13M

-1782.0%

EBITDA

$359.91M

-2808.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$837.84M

-37.5%

Accounts Receivable

$323.40M

-22.0%

Inventory

$0.00

N/A

Long Term Debt

$974.36M

+89.0%

Short Term Debt

$15.34M

-92.3%

Return on Assets

-28.14%

N/A

Return on Invested Capital

-0.76%

N/A

Free Cash Flow

$41.04M

+226.7%

Operating Cash Flow

$48.80M

+286.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MYGNMyriad Genetics, Inc.
$4.75+2.37%
NUTXNutex Health, Inc.
$94.66+0.64%
REPLReplimune Group, Inc.
$6.89+1.92%
MGTXMeiraGTx Holdings plc
$7.35-1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
QQQInvesco QQQ Trust
$593.02-0.00%

Questions About EVH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.